A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)

NCT00307814 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

519

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Chronic Renal Insufficiency

Interventions

DRUG: Epoetin Alfa

Sponsor

Ortho Biotech Products, L.P.